MDG
← Back to blog

Thinking About a Clinical Trial? Here's What Usually Happens Before You Join

Valerii Vasylevskyi, MD · May 1, 2026 · 3 min read

Thinking About a Clinical Trial? Here's What Usually Happens Before You Join

Clinical trials can seem daunting initially. Many prospective participants worry about immediate commitments, instant treatment initiation, or surrendering autonomy over their medical decisions.

However, the reality typically unfolds as a deliberate, methodical, question-focused journey.

A clinical trial represents a research investigation involving human participants. These studies enable researchers to assess whether a medical intervention proves safe, beneficial, or warrants deeper investigation. Research may focus on pharmaceutical treatments, medical devices, surgical techniques, genetic evaluations, wellness metrics, or ongoing safety monitoring.

Crucially: "finding a trial is not the same as joining a trial." Most individuals navigate multiple phases before determining whether participation aligns with their needs.

Step 1: Identifying a Potential Study

Awareness often comes through physician referrals, patient advocacy organizations, medical institutions, public databases, or patient navigation organizations.

Public registries like ClinicalTrials.gov contain accessible study information: recruitment status, qualifications, contact persons, geographic locations, and occasionally outcome data. Medical Development Group directs patients toward ClinicalTrials.gov, Health Canada resources, NIH databases, WHO ICTRP, GARD, and FDA materials.

At this stage, information gathering takes priority over immediate decisions. Key questions include location, current recruitment status, age requirements, research objectives, and enrollment contacts.

Step 2: Evaluating Fit With Personal Circumstances

Diagnosis relevance doesn't guarantee suitability. Trials frequently mandate specific prerequisites such as confirmed genetic diagnostics, particular disease progression stages, previous medication histories, particular test measurements, site accessibility, appointment frequency, or schedule compatibility with employment or family responsibilities.

This assessment proves particularly vital for uncommon conditions, where limited study locations and complex eligibility language may confound families without professional interpretation support.

Step 3: Contacting the Research Team

For apparently suitable studies, engagement with researchers represents the logical next move. Registry contact individuals exist specifically to address enrollment inquiries. No scientific expertise is required — straightforward communication suffices: "I discovered this study and want to explore whether my situation matches. What initial information would help you assess screening eligibility?"

Step 4: Preliminary Screening Assessment

Teams typically conduct informal evaluation — often termed "pre-screening" or "screening" — requesting details regarding diagnosis, age, medical documentation, treatment background, examination findings, current medications, and geographic location.

This represents exploratory investigation only, not acceptance confirmation. It establishes whether formal evaluation merits consideration.

Step 5: Reviewing Informed Consent

Before participation, researchers must thoroughly communicate what involvement entails. Informed consent transcends documentation; it constitutes an instructional undertaking facilitating comprehension of research goals, possible complications, potential advantages, other options, confidentiality measures, schedule demands, and individual protections. "FDA guidance describes informed consent as a required process for protecting human subjects in FDA-regulated research." Participants retain question-asking privileges and deliberation timeframes.

Step 6: Consulting Your Healthcare Provider

Intriguing research might still prove unsuitable personally. Your established physician facilitates evaluation regarding compatibility with contemporary management, pharmaceutical regimens, logistical demands, and supervision requirements.

Medical Development Group emphasizes this distinction: the organization furnishes educational resources and navigation guidance, excluding clinical determinations, eligibility decisions, or enrollment procedures — responsibilities belonging to qualified research teams and healthcare professionals.

Reframing Your Approach

You're not "requesting medical treatment" conventionally. Rather, you're investigating whether study parameters correspond with your medical circumstances, individual objectives, and realistic lifestyle demands.

Commencement involves not obligation, but understanding.